{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:56:58Z","timestamp":1790395018477,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jvs.2020.02.026","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T20:11:23Z","timestamp":1586376683000},"page":"1626-1635.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ten-year clinical outcomes for patients undergoing lower extremity endovascular interventions"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-3832","authenticated-orcid":false,"given":"Tomonori","family":"Katsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Hiramori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tomoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2020.02.026_bib1","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"Diehm","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib2","first-page":"e686","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: executive Summary: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"Suppl S","key":"10.1016\/j.jvs.2020.02.026_bib4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib5","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejvs.2013.09.024","article-title":"Perioperative complications after aorto-iliac stenting: associated factors and impact on follow-up cardiovascular prognosis","volume":"47","author":"Iida","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1583\/13-4242.1","article-title":"Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis","volume":"20","author":"Indes","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","article-title":"A\u00a0systematic review of endovascular treatment of extensive aortoiliac occlusive disease","volume":"52","author":"Jongkind","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib9","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcin.2017.05.015","article-title":"Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial","volume":"10","author":"Krankenberg","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.CIR.70.4.619","article-title":"Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up","volume":"70","author":"Gallino","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1583\/11-3581.1","article-title":"Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis","volume":"18","author":"Iida","year":"2011","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jvs.2016.05.073","article-title":"Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years","volume":"64","author":"Stavroulakis","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005531","article-title":"Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia)","volume":"10","author":"Iida","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib16","article-title":"Long-term follow-up of the PADI Trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia","volume":"6","author":"Spreen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.02.026_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jvs.2010.03.050","article-title":"Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent","volume":"52","author":"Soga","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1583\/13-4510MR.1","article-title":"Propensity score analysis of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia","volume":"21","author":"Soga","year":"2014","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/CIRCINTERVENTIONS.110.958249","article-title":"Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation","volume":"3","author":"Yamaji","year":"2010","journal-title":"Circulation Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","article-title":"Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome","volume":"55","author":"Sartipy","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehp553","article-title":"Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease","volume":"31","author":"van Kuijk","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2020.02.026_bib24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jacc.2007.11.077","article-title":"Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease","volume":"51","author":"Welten","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib25","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib27","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1253\/circj.CJ-12-0492","article-title":"Contemporary outcomes after endovascular treatment for aorto-iliac artery disease","volume":"76","author":"Soga","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2020.02.026_bib28","doi-asserted-by":"crossref","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib29","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/01.CIR.0000035649.39669.CE","article-title":"Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)","volume":"106","author":"Mukherjee","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib30","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"Lammer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A\u00a0polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2020.02.026_bib32","first-page":"1259","article-title":"SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent","volume":"89","author":"Garcia","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib33","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/1526602816650206","article-title":"Twelve-month results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease","volume":"23","author":"Muller-Hulsbeck","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCINTERVENTIONS.111.967794","article-title":"Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?","volume":"5","author":"Speck","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib36","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.02.026_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1526602819870309","article-title":"Mortality risk following application of a paclitaxel-coated stent in femoropopliteal lesions","volume":"26","author":"Katsuki","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib38","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.jcin.2015.08.020","article-title":"15-Year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease","volume":"8","author":"Kumakura","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib39","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jvs.2016.05.073","article-title":"Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years","volume":"64","author":"Stavroulakis","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib40","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejvs.2017.07.005","article-title":"Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study","volume":"54","author":"Baubeta Fridh","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib42","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1253\/circj.CJ-12-0492","article-title":"Contemporary outcomes after endovascular treatment for aorto-iliac artery disease","volume":"76","author":"Soga","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2020.02.026_bib43","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2008.07.060","article-title":"Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality","volume":"52","author":"Criqui","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1583\/11-3581.1","article-title":"Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis","volume":"18","author":"Iida","year":"2011","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib45","doi-asserted-by":"crossref","first-page":"e007702","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.02.026_bib46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.CIR.70.4.619","article-title":"Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up","volume":"70","author":"Gallino","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib47","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"Diehm","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib48","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.02.026_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejvs.2013.09.024","article-title":"Perioperative complications after aorto-iliac stenting: associated factors and impact on follow-up cardiovascular prognosis","volume":"47","author":"Iida","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib50","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.02.026_bib51","article-title":"Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia","volume":"6","author":"Spreen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.02.026_bib52","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.02.026_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1583\/13-4242.1","article-title":"Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis","volume":"20","author":"Indes","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.02.026_bib54","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","article-title":"A\u00a0systematic review of endovascular treatment of extensive aortoiliac occlusive disease","volume":"52","author":"Jongkind","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.02.026_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420302986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420302986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:28:52Z","timestamp":1760041732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521420302986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0741521420302986"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.02.026","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year clinical outcomes for patients undergoing lower extremity endovascular interventions","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}